4//SEC Filing
D ALONZO THOMAS 4
Accession 0001209191-13-021066
CIK 0001009356other
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 4:25 PM ET
Size
15.9 KB
Accession
0001209191-13-021066
Insider Transaction Report
Form 4
D ALONZO THOMAS
Director
Transactions
- Sale
Common Stock
2013-04-08$49.43/sh−5,107$252,439→ 85,533 total - Exercise/Conversion
Option to Buy Common Stock
2013-04-08−15,000→ 0 totalExercise: $7.60Exp: 2013-07-24→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2013-04-08$7.60/sh+15,000$114,000→ 90,640 total - Sale
Common Stock
2013-04-08$50.26/sh−1,079$54,231→ 84,454 total
Holdings
- 260(indirect: By LP)
Common Stock
- 15,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (15,000 underlying) - 1,080(indirect: By Trust)
Common Stock
- 22,500
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (22,500 underlying) - 6,500(indirect: By Spouse)
Common Stock
Footnotes (5)
- [F1]The exercise and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2013.
- [F2]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $49.18 to $50.1, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $50.18 to $50.41, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
- [F4]The shares are held by the Rachel L. D'Alonzo Rev Trust U/A DTD 10/24/2001 for which the Reporting Person serves as co-trustee.
- [F5]Options are 100% vested.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeother
Related Parties
1- filerCIK 0001212667
Filing Metadata
- Form type
- 4
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 4:25 PM ET
- Size
- 15.9 KB